NeoGenomics, Inc. Proceeds from Sale of Productive Assets
NeoGenomics, Inc. (NEO) reported Proceeds from Sale of Productive Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2025-02-18
- NeoGenomics, Inc. proceeds from sale of productive assets for the quarter ending 2023-12-31 was $0.00.
- NeoGenomics, Inc. proceeds from sale of productive assets for the quarter ending 2023-09-30 was $0.00.
- NeoGenomics, Inc. proceeds from sale of productive assets for the quarter ending 2022-12-31 was $0.00.
- NeoGenomics, Inc. proceeds from sale of productive assets for the quarter ending 2022-09-30 was $0.00.
- NeoGenomics, Inc. proceeds from sale of productive assets for fiscal 2024 was $0.00.
- NeoGenomics, Inc. proceeds from sale of productive assets for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- NeoGenomics, Inc. proceeds from sale of productive assets for fiscal 2022 was $12.10M.
- NeoGenomics, Inc. proceeds from sale of productive assets for fiscal 2021 was $0.00.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $12.10M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $12.10M 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $12.10M 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 10-K · filed 2024-02-20 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |